Department of Medicine
Akash Patnaik is a medical oncologist specializing in the care of patients with genitourinary cancers, including prostate, bladder, kidney, and testicular cancers. He also has a strong interest in the development of novel therapeutics for treatment of advanced solid tumors. His work focuses on translating novel therapies from the laboratory to early stage clinical trials. He is interested in developing personalized patient models of disease in order to interpret therapeutics, develop biomarkers, and help patients make informed decisions about their care. Patnaik serves as the director of the University of Chicago Medicine’s prostate cancer experimental therapeutics research program.
He has received numerous recognitions for his work, including the AACR-Astellas USA Foundation Fellowship in Clinical/Translational Cancer Research, a Harvard-MIT Clinician-Investigator Training Program Fellowship, a Prostate Cancer Foundation Young Investigator Award, and a US Department of Defense Prostate Cancer Physician Research Training Award.
Patnaik holds an MD from Penn State College of Medicine, as well as a PhD in cell and molecular biology from that institution. He completed his residency in internal medicine at the Mayo Clinic, a clinical fellowship in hematology/oncology at Beth Israel Deaconess Medical Center, and a research fellowship in cancer biology at Harvard Medical School. He also received an MMSc in clinical investigation from Harvard Medical School.